Proton Therapy in Hodgkin Lymphoma Yields Favorable Acute Toxicity Profile
October 19th 2017A new study found that Hodgkin lymphoma patients treated with consolidative proton therapy after chemotherapy had “excellent” early relapse-free survival rates and no early grade 3 radiation-related toxicities.